Who invested in Elicio Therapeutics?
Elicio Therapeutics's investors include EFung Capital, Livzon Mabpharm and Biotechnology Industries.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$78Mraised across 3 rounds since 2019, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Source recorded
Reported by FinSMEsSEC filing: $7.0M sold, first sale Sept 2019
From the SEC filings it signed: 4 on the team.
On the board, as filediAllen NissensonCarol AsheJay VenkatesanJulian AdamsKaren WilsonRobert RuffoloYekaterina Chudnovsky
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Elicio Therapeutics's investors include EFung Capital, Livzon Mabpharm and Biotechnology Industries.
Elicio Therapeutics has raised $78M across 3 rounds since 2019.
Elicio Therapeutics's most recent round was an Undisclosed round of $15M in Jul 2026.
Elicio Therapeutics's largest round on record is $33M (Series B), in Oct 2019.
Elicio Therapeutics's first round on record, in Oct 2019, was backed by EFung Capital, Livzon Mabpharm and Biotechnology Industries.
Elicio Therapeutics's latest named round is an Undisclosed round, in Jul 2026.
Elicio Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.